Home Krystal Biotech

Krystal Biotech

In operation
Post-IPO Round
Gene Therapy Developer

Basic Information

Krystal Biotech, Inc. is a clinical-stage gene therapy company developing effective and innovative treatments for skin diseases using its proprietary Skin TARgeted Delivery (STAR-D) platform. While the company is initially focused on developing topical and intradermal “off-the-shelf” new therapies for rare and orphan dermatological indications, it is expanding the use of its groundbreaking STAR-D technology to target and treat other skin conditions.
Krystal Biotech, Inc.
Pittsburgh,Pennsylvania,United States of America
101~500 people
January 01, 2015
inquiries@krystalbio.com